GLP-1 and Sleep Apnea: Can Ozempic, Wegovy, or Zepbound Help?

Available online. Shipped directly to your door anywhere in the US.

What is obstructive sleep apnea?

Obstructive sleep apnea (OSA) is a condition where the airway repeatedly becomes blocked during sleep. This causes breathing pauses, snoring, poor sleep quality, and daytime fatigue. OSA is strongly linked to obesity, especially excess weight around the neck and upper airway.

Untreated sleep apnea increases the risk of:

• High blood pressure
• Heart disease
• Stroke
• Type 2 diabetes
• Daytime sleepiness and accidents

How does obesity cause sleep apnea?

Excess fat around the neck, throat, and chest can narrow the airway and put pressure on breathing muscles. When the muscles relax during sleep, the airway can collapse more easily, leading to apnea events.

Losing even 5% to 10% of body weight can reduce the severity of sleep apnea in many people. Larger weight loss, such as the 15% to 22% seen with GLP-1 medications, may significantly improve or resolve OSA in some patients.

Can GLP-1 medications help sleep apnea?

Yes. By producing significant weight loss, GLP-1 medications can reduce fatty tissue around the airway and decrease the number of apnea events. Improvements may include:

• Fewer breathing pauses per hour
• Reduced snoring
• Better oxygen levels during sleep
• Less daytime sleepiness
• Improved blood pressure

Zepbound is FDA-approved for sleep apnea

In 2025, Zepbound (tirzepatide) became the first GLP-1 medication approved by the FDA to treat moderate to severe obstructive sleep apnea in adults with obesity. This approval was based on clinical trials showing that tirzepatide reduced apnea events and improved sleep quality.

This is significant because it means some insurance plans, including Medicare Part D in certain cases, may cover Zepbound for OSA even if they do not cover it for weight loss alone.

Wegovy and Ozempic for sleep apnea

Wegovy and Ozempic are not specifically FDA-approved for sleep apnea, but weight loss from these medications can still improve OSA symptoms. Wegovy has also been shown to reduce cardiovascular risk in people with obesity and heart disease.

How much weight loss improves sleep apnea?

Research suggests:

• A 5% to 10% weight loss can reduce apnea events
• A 10% to 15% weight loss can lead to significant improvement
• Greater weight loss may reduce or eliminate the need for CPAP in some patients

However, weight loss alone does not cure sleep apnea for everyone. Many patients still need CPAP or other treatments.

Should you stop CPAP after losing weight on GLP-1s?

Do not stop CPAP therapy without talking to your doctor. Your provider may recommend a repeat sleep study to see if your OSA has improved enough to reduce or stop CPAP use. Many people still need some level of treatment even after significant weight loss.

How to get screened for sleep apnea

Common symptoms of sleep apnea include:

• Loud, chronic snoring
• Pauses in breathing during sleep
• Gasping or choking at night
• Excessive daytime sleepiness
• Morning headaches
• Difficulty concentrating
• High blood pressure

If you have these symptoms, talk to your provider about a sleep study. Diagnosing OSA is the first step to getting treatment and potentially qualifying for GLP-1 coverage.

Frequently asked questions

Can GLP-1s cure sleep apnea?

They cannot cure OSA, but significant weight loss can reduce symptoms and may reduce the need for CPAP in some patients.

Which GLP-1 is best for sleep apnea?

Zepbound is currently the only GLP-1 FDA-approved for moderate to severe OSA in adults with obesity.

Will insurance cover Zepbound for sleep apnea?

Coverage is improving, including some Medicare Part D plans for OSA. Check with your insurer or a telehealth provider.

How long until sleep apnea improves on GLP-1s?

Some improvement may occur within a few weeks of weight loss, but significant changes usually take several months.

Can I use GLP-1s and CPAP together?

Yes. Many patients use both until their OSA improves enough to adjust CPAP settings or discontinue treatment under medical guidance.

Conclusion

GLP-1 medications can significantly improve sleep apnea by reducing weight and airway pressure. Zepbound is FDA-approved for OSA, making it an important option for people with both obesity and sleep apnea. If you snore, feel tired during the day, or have been diagnosed with OSA, weight-loss treatment may help.

Check your eligibility for a US telehealth GLP-1 program and speak with a provider about whether semaglutide or tirzepatide is right for your weight and sleep apnea goals.